CTS.NYSECts CORP

Form 4: CTS Corp CEO Kieran O'Sullivan Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4


CTS Corp CEO Kieran O'Sullivan sold 14,976 shares of common stock at an average price of $47.1273 per share on March 28, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • On March 28, 2024, Kieran M. O'Sullivan, the President and CEO of CTS Corp, sold 14,976 shares of CTS common stock.
  • The sale was executed at a weighted average price of $47.1273 per share, with individual transaction prices ranging from $47.00 to $47.24.
  • The transaction was conducted under a pre-existing 10b5-1 trading plan adopted on May 23, 2023.
  • Following the reported transaction, O'Sullivan still beneficially owns 501,637 shares of CTS Corp common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-arranged plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Executive stock sales are a common occurrence and are often planned in advance using 10b5-1 plans to avoid accusations of insider trading. The market typically analyzes these sales in the context of the executive's overall holdings and the company's performance.

Comparison to Industry Standards

  • Executive stock sales are common across publicly traded companies.
  • The use of a 10b5-1 plan is a standard practice to ensure compliance with insider trading regulations, similar to practices at companies like Texas Instruments or Analog Devices.
  • The size of the transaction is relatively small compared to the executive's overall holdings, which is a common scenario.

Stakeholder Impact

  • The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the pre-planned nature of the transaction and the relatively small number of shares sold compared to the CEO's total holdings.

Key Dates

DateDescription
May 23, 2023Date the reporting person adopted the 10b5-1 plan.
March 28, 2024Date of the transaction (sale of shares).
April 01, 2024Date of the signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.